Mirum Pharmaceuticals (MIRM) Shares Outstanding (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Shares Outstanding (Entity) of $60.9 million for Q1 2026, up 23.2% year-over-year from $49.5 million in Q1 2025, and up 17.4% quarter-over-quarter from $51.9 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Shares Outstanding (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $60.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 23.2% year-over-year to $60.9 million; the TTM figure through Mar 2026 stood at $60.9 million (up 23.2% YoY), while the FY2025 annual figure was $51.9 million, up 7.36% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $60.9 million, up from $51.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $60.9 million in Q1 2026, with the low at $31.7 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $47.1 million (2024), against an average of $44.8 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) advanced 26.57% in 2023, then advanced 2.95% in 2024.
- Mirum Pharmaceuticals' Shares Outstanding (Entity) stood at $37.0 million in 2022, then gained by 26.43% to $46.7 million in 2023, then increased by 3.46% to $48.3 million in 2024, then climbed by 7.36% to $51.9 million in 2025, then gained by 17.4% to $60.9 million in 2026.
- Business Quant data shows MIRM's Shares Outstanding (Entity) at $60.9 million in Q1 2026, $51.9 million in Q4 2025, and $51.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 63.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.37 Mn |
| Mar 31, 2026 | 58.85 Mn |
| Dec 31, 2025 | 50.20 Mn |
| Sep 30, 2025 | 50.64 Mn |
| Jun 30, 2025 | 49.73 Mn |
| Mar 31, 2025 | 48.89 Mn |
| Dec 31, 2024 | 47.52 Mn |
| Sep 30, 2024 | 47.78 Mn |
| Jun 30, 2024 | 47.24 Mn |
| Mar 31, 2024 | 46.93 Mn |
| Dec 31, 2023 | 40.89 Mn |
| Sep 30, 2023 | 41.10 Mn |
| Jun 30, 2023 | 38.11 Mn |
| Mar 31, 2023 | 37.68 Mn |
| Dec 31, 2022 | 33.84 Mn |
| Sep 30, 2022 | 34.93 Mn |
| Jun 30, 2022 | 32.16 Mn |
| Mar 31, 2022 | 31.30 Mn |
| Dec 31, 2021 | 30.32 Mn |
| Sep 30, 2021 | 30.37 Mn |